Riskpilot← Back to searchSign inGet full accessGN Injection Moulding AB
ABActiveOrg 5592691934Varggatan 13Processing and finishing of plastic products · NACE 2225Est. 20200 employees
Revenue 2024
SEK 15,1M
+1324% vs 2023
EBITDA margin
-29.2%
+73% vs 2023
Equity ratio
0.4%
Financial strength
Net profit 2024
SEK 173K
+811% vs 2023
| Revenue | SEK 15,1M | +1324% |
| EBITDA | SEK -4,4M | +73% |
| Net profit | SEK 173K | +811% |
| Total assets | SEK 66,2M | +5% |
| Equity | SEK 287K | +150% |
| Employees | 0 | — |
Legal name
GN Injection Moulding AB
Org number
5592691934
Legal form
Aktiebolag
NACE code
2225 · Processing and finishing of plastic products
Founded
1 september 2020
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av externa firmatecknarna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva formsprutning, ytbeläggningar av plast och därmed förenlig verksamhet.
Address
Varggatan 13
Email
morad@gntobacco.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 1 060 | 15 092 |
| Staff expenses | — | — | — | — |
| EBITDA | −11 | 331 | −16 032 | −4 408 |
| Depreciation & amort. | −0 | −0 | −0 | −6 956 |
| EBIT | −11 | 331 | −16 032 | −11 364 |
| Net financials | −34 | −308 | −1 203 | −1 415 |
| Profit before tax | 35 | 23 | 28 | 221 |
| Tax | −7 | −5 | −9 | −48 |
| Net profit | 28 | 18 | 19 | 173 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 14 937 | 40 755 | 62 853 | 66 200 |
| Equity | 78 | 96 | 115 | 287 |
| Long-term debt | 14 700 | 35 857 | 45 221 | 50 816 |
| Short-term debt | 159 | 4 802 | 2 029 | 12 608 |
| Total debt | 14 859 | 40 659 | 47 250 | 63 424 |
EBITDA margin
-29.2%
This company
15.8%
Market median
-285% vs market
20212024
Equity ratio
0.4%
This company
38.2%
Market median
-99% vs market
20212024
Return on equity
60.3%
This company
18.4%
Market median
+228% vs market
20212024
Net profit margin
1.1%
This company
8.1%
Market median
-86% vs market
20212024
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20212024
Debt / equity
229.66×
This company
0.62×
Market median
-36942% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
AJ Chief Executive Officer | Chief Executive Officer | 2020 |
GM External Signatory | External Signatory | 2022 |
GN External Signatory | External Signatory | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Giviton Holding AB
GN Injection Moulding AB Board members of GN Injection Moulding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Abdolmorad Jalily Khiabany | Chief Executive Officer | 0 companies |
| Gagik Markosyan | External Signatory | 0 companies |
| Gevorg Nalbandyan | External Signatory | 0 companies |
| Antonina Nalbandyan | Deputy Board Member | 0 companies |
| Tigran Barseghyan | Deputy Board Member | 0 companies |
| Naira Nalbandyan | Board of Directors | 0 companies |
| Sergej Nalbandjan | Board of Directors | 0 companies |